Home Drug Codes J Codes J1744 · FIRAZYR
Updated July 1st, 2026

FIRAZYR J Code: J1744

Injection, icatibant, 1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
15
View NDC crosswalk →
Self-Administered Drug Exclusion 7 Medicare Administrative Contractors list J1744 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: CGS, First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Injection, icatibant, 1 mg
HCPCS Added Date January 1, 2013
Manufacturer Multiple Manufacturers
Route of Administration Subcutaneous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Injection, Solution

About FIRAZYR

Firazyr is a medication aligned to the HCPCS J Code: J1744 for billing, pricing, and reimbursement purposes in the United States. It is an Immunology drug administered via the subcutaneous route and manufactured by multiple companies.

According to CMS Drug Use Information: Icatibant is used to treat sudden attacks of a certain immune system condition passed down through families called hereditary angioedema (HAE). Although this medication is not a cure for HAE, icatibant may lessen the symptoms of an attack such as rapid swelling and pain of the hands, arms, feet, legs, face, tongue, and upper airway. When attacks involve the stomach/intestines, symptoms may include abdominal pain/cramps, diarrhea, constipation, or vomiting. Attacks may happen at any time. However, stress, injury, or illness may trigger attacks in some people. Icatibant works by blocking the action of a natural substance in the body called bradykinin. Bradykinin is thought to cause the symptoms of an HAE attack.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

15 NDC packages are crosswalked to J1744. Package detail is available to logged-in subscribers.

Login to view 15 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

FIRAZYR Pricing & Reimbursement

J1744 Private Payer Reimbursement
$66.75 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

FIRAZYR CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

CMS does not include Firazyr (J1744) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1744. Wastage billing guide →

FIRAZYR Medically Unlikely Edits (MUE)

The most billing units of J1744 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
30 units / day
= 30 mg per day
Hospital Outpatient
90 units / day
= 90 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

FIRAZYR Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hereditary Angioedema (HAE) Hereditary Angioedema (HAE), acute attacks
Drug Class
Bradykinin B2 Receptor Antagonist [EPC]Bradykinin B2 Receptor Antagonists [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Firazyr billing and coding guide?
We have not yet identified a manufacturer source of Firazyr billing and coding information.
Are there any available Firazyr patient assistance programs?
Our team did not identify a source for Firazyr patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Firazyr prescribing information?
FIRAZYR prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Firazyr side effect information?
Our team has not yet identified a source of side effects information for FIRAZYR. Please check back in a few weeks.
Does billing FIRAZYR require JZ/JW wastage modifiers?
CMS does not include FIRAZYR (J1744) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1744. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.